Related references
Note: Only part of the references are listed.Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart
Pawel Dobrzyn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver
A. Mallat et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration
M. Rajesh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
P. Pacher et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Liver: An organ with predominant innate immunity
Bin Gao et al.
HEPATOLOGY (2008)
Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Mohanraj Rajesh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Pharmacological inhibition of CB1 cannabinoid raceptor protects against doxorubicin-induced cardiotoxicity
Partha Mukhopadhyay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary-Bobo et al.
HEPATOLOGY (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
N. Mendez-Sanchez et al.
LIVER INTERNATIONAL (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
Ariane Mallat et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptors
L. Moezi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli
Y Tian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C
C Hézode et al.
HEPATOLOGY (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
The cannabinoid system and immune modulation
TW Klein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation
I Lavon et al.
MOLECULAR PHARMACOLOGY (2003)
Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
J Ros et al.
GASTROENTEROLOGY (2002)
Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis
S Bátkai et al.
NATURE MEDICINE (2001)
Share Paper
